Previous 10 |
VANCOUVER, British Columbia, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (Nasdaq: DRUG) (CSE: DRUG), a biotechnology company focused on developing novel drugs for the targeted treatment of neur...
VANCOUVER, British Columbia, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (Nasdaq: DRUG) (CSE: DRUG), a biotechnology company focused on developing novel drugs for the targeted treatment of neur...
FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Harmony Biosciences Holdings, Inc. is Set To Initiate Phase 3 Clinical Trial For Treatment Of Idiopathic Hypersomnia ” Harmony Biosciences Holdings, Inc. (...
— Hundreds of de novo patentable psychedelic-based compounds created through discovery program — — Company plans to announce lead molecule in first quarter of 2022 — VANCOUVER, British Columbia, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Bright Minds Bioscienc...
FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Zosano Pharma Corporation (NASDAQ: ZSAN) Announces the Successful Formulation of a COVID-19 Vaccine Candidate on its Microneedle Patch System ” Zosano Phar...
News, Short Squeeze, Breakout and More Instantly...
Bright Minds Biosciences Inc. Company Name:
DRUG Stock Symbol:
NASDAQ Market:
Bright Minds Biosciences Inc. Website:
Algoma Steel Group Inc. (ASTL) is expected to report for Q3 2024 CTS Corporation (CTS) is expected to report for Q4 2023 Xylem Inc. New (XYL) is expected to report $0.96 for Q4 2023 TIM S.A. American Depositary Shares (Each representing 5) (TIMB) is expected to report for Q4 2023 ...
Bright Minds Biosciences Inc. (DRUG) is expected to report for quarter end 2023-12-31